Mursla Bio加入欧盟资助的EverEST财团,推进临床诊断EV研究。 Mursla Bio joins EU-funded EVEREST consortium to advance EV research for clinical diagnostics.

Mursla Bio,EV科学领先者,加入了EverEST财团,目的是推动欧洲各地的EV研究和临床应用。 Mursla Bio, a leader in EV science, has joined the EVEREST consortium, aiming to advance EV research and clinical applications across Europe. 该项目由欧洲联盟供资,涉及22个机构和80多名研究人员,重点将放在扩大EV产品的规模和商业化上,特别是用于临床诊断。 Funded by the European Union and involving 22 institutions and over 80 researchers, the project will focus on scaling and commercializing EV products, particularly for clinical diagnostics. 在都柏林大学学院的协调下,该倡议寻求开发创新诊断工具,使数百万患者受益。 Coordinated by University College Dublin, the initiative seeks to develop innovative diagnostic tools benefiting millions of patients.